IPA furthers on home SARS-CoV-2 diagnostic test (OTCMKTS:IPATF)

ImmunoPrecise Antibodies (OTCQB:IPATF) updates on their NSERC-funded partnership with the University of Victoria for the generation of a real-time cell-phone-based COVID-19 antibody diagnostic test.

In May, the company announced a partnership objective to develop a colorimetric, easy to use, saliva test for the detection and screening of SARS-CoV-2.

The test is designed to have a detectable color change that can be easily measured using a cell phone camera and application.

Upon successful commercialization of the diagnostic kit, the company has committed to paying 5% of global net revenue to the University of Victoria.

Press Release

Source Article